chevron_leftBack
As of 24 April 2025, Eurobio Scientific Société anonyme has a market cap of $279.44M USD, ranking #15321 globally and #218 in France. It ranks #1505 in the Healthcare sector, and #176 in the Medical Devices industry.
Key Stats
Market Cap
$279.44MUSD
245.57M EUR
Enterprise Value
$287.2MUSD
252.38M EUR
Revenue (TTM)
$164.69MUSD
144.73M EUR
EBITDA (TTM)
$23.47MUSD
20.63M EUR
Net Income (TTM)
$7.56MUSD
6.64M EUR
EBITDA Margin
14%
Profit Margin
4.6%
PE Ratio
40.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Denis Fortier
open_in_new
Employees
300
Founded
1997
Website
eurobio-scientific.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 0.8% | -3.6% | -3.4% | -5.2% | 65% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ALERS
Eurobio Scientific Bearer and/or Registered shares issued from reverse split
ISIN: FR0013240934
Shares Out.:
Shares Outstanding:
10.005M1
Shares Float:
3.011M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
24.45 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Eurobio Scientific Société anonyme
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
